Physician profile
Kevin Wingert
NPI 1083608301
$701.10
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.80 · 2020: $20.33 · 2021: $452 · 2023: $58.50 · 2024: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $405.51 | 2021-2024 | Qulipta, Ubrelvy |
| Biohaven Pharmaceuticals, INC. | $121.24 | 2021 | |
| Lilly USA, LLC | $36.76 | 2019-2023 | Jardiance |
| Amgen INC. | $24.11 | 2024 | Repatha, Otezla |
| Esperion Therapeutics, INC. | $22.06 | 2023 | Nexletol |
| Medtronic, INC. | $21.18 | 2021 | |
| Therapeuticsmd, INC. | $20.33 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.96 | 2019 | |
| Seqirus USA INC | $17.22 | 2024 | Fluad, Flucelvax |
| Novartis Pharmaceuticals Corporation | $13.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Wingert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.